Treatment guidelines for nonvalvular atrial fibrillation (AF) recommend use of non–vitamin K antagonist oral anticoagulants (NOACs) over warfarin. However, clinical trials did not include individuals with post cardiac surgery AF. We sought to compare outcomes with NOACs vs warfarin for new onset post cardiac surgery AF.
Non–Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial Fibrillation
Submitted by: Christopher Anderson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.12.031
Keywords:
Author(s): Victor Nauffal, MD, Ludovic Trinquart, PhD, Asishana Osho, MD, Thoralf M. Sundt, MD, Steven A. Lubitz, MD, MPH, Patrick T. Ellinor, MD, PhD
1 Comment
Patient operated with MVR with Tissue valve with AF ablation post op 2 years reverted to A F with controlled heart rate. What is better NOACs or warfarin